HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Garbers Selected Research

olamkicept

1/2022Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc).
1/2021Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
2/2014Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities.
6/2011The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Garbers Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 06/2011
22Inflammation (Inflammations)
01/2022 - 06/2011
7Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 06/2011
7Rheumatoid Arthritis
01/2020 - 03/2011
4Infections
12/2021 - 09/2014
3Atherosclerosis
01/2022 - 02/2014
3Type 2 Diabetes Mellitus (MODY)
11/2021 - 01/2019
3Craniosynostoses (Craniosynostosis)
01/2021 - 10/2018
3Carcinogenesis
01/2018 - 02/2016
3Autoimmune Diseases (Autoimmune Disease)
01/2018 - 06/2011
2COVID-19
01/2022 - 02/2021
2Obesity
11/2021 - 01/2018
2Fatty Liver
11/2021 - 10/2019
2Body Weight (Weight, Body)
10/2021 - 06/2014
2Hepatocellular Carcinoma (Hepatoma)
07/2021 - 11/2019
2Arthritis (Polyarthritis)
01/2017 - 01/2016
2Asthma (Bronchial Asthma)
02/2016 - 06/2011
2Peritonitis
02/2014 - 06/2011
2Colonic Neoplasms (Colon Cancer)
02/2014 - 06/2011
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Hematologic Diseases (Blood Diseases)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Lymphopenia (Lymphocytopenia)
01/2022
1Polycythemia Vera
01/2022
1Splenomegaly
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Chondrocalcinosis (Pseudogout)
12/2021
1Osteoarthritis
12/2021
1Cutaneous Leishmaniasis
12/2021
1MASS syndrome
11/2021
1Mucolipidoses (Sialidosis)
11/2021
1Maternal Obesity
10/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
03/2020
1Neoplasm Metastasis (Metastasis)
03/2020
1Cytokine Release Syndrome
01/2020
1Weight Gain
10/2019
1Muscular Atrophy (Muscle Atrophy)
10/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2018
1Castleman Disease (Castleman's Disease)
01/2018
1Intestinal Neoplasms (Intestinal Cancer)
01/2018
1Urinary Tract Infections (Urinary Tract Infection)
01/2018
1Experimental Arthritis
01/2017
1Uveitis
01/2017

Drug/Important Bio-Agent (IBA)

32Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2011
14CytokinesIBA
01/2022 - 09/2013
10Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
07/2021 - 06/2011
7Interleukin-11 (Interleukin 11)IBA
01/2022 - 04/2012
5InterleukinsIBA
01/2018 - 02/2016
4Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2012
4olamkiceptIBA
01/2022 - 06/2011
4Metalloproteases (Metalloproteinases)IBA
01/2021 - 10/2016
4Monoclonal AntibodiesIBA
01/2020 - 09/2014
3Cytokine Receptor gp130IBA
01/2022 - 01/2016
3Biological ProductsIBA
01/2022 - 10/2019
3Interleukin-11 Receptors (Interleukin 11 Receptor)IBA
12/2021 - 10/2018
3Peptide Hydrolases (Proteases)FDA Link
06/2019 - 01/2016
2Transcription Factors (Transcription Factor)IBA
01/2022 - 07/2021
2Glucose (Dextrose)FDA LinkGeneric
10/2021 - 10/2019
2Ciliary Neurotrophic Factor (CNTF)IBA
10/2019 - 06/2014
2DisintegrinsIBA
06/2019 - 10/2016
2Pharmaceutical PreparationsIBA
01/2019 - 02/2014
1ZincIBA
01/2022
1CholesterolIBA
01/2022
1CreatinineIBA
01/2022
1CalreticulinIBA
01/2022
1LipidsIBA
01/2022
1Lipoproteins (Lipoprotein)IBA
01/2022
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2022
1LDL CholesterolIBA
01/2022
1Lipoprotein(a)IBA
01/2022
1LDL Receptors (LDL Receptor)IBA
01/2022
1Recombinant ProteinsIBA
01/2022
1CalciumIBA
12/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2021
1NF-kappa B (NF-kB)IBA
07/2021
1Tiopronin (Thiola)FDA Link
01/2021
1Amino AcidsFDA Link
01/2021
1tocilizumab (atlizumab)FDA Link
01/2020
1Therapeutic UsesIBA
10/2019
1AcitretinFDA Link
01/2019
1RetinoidsIBA
01/2019
1BuffersIBA
01/2019
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
01/2019
1ChemokinesIBA
01/2018
1Janus Kinase InhibitorsIBA
01/2018
1CateninsIBA
01/2018
1Janus KinasesIBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Blocking AntibodiesIBA
01/2018
1Epidermal Growth Factor (EGF)IBA
01/2018

Therapy/Procedure

5Therapeutics
01/2022 - 12/2016
2Sutures (Suture)
01/2021 - 10/2018
1Radiotherapy
03/2020
1Drug Therapy (Chemotherapy)
03/2020
1Intravitreal Injections
01/2017